Evidence map›Paper›PMID 26016555›Full record

ReviewMolecules (Basel, Switzerland)2015

Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions.

Jagat R Kanwar, Kislay Roy, Yogesh Patel, Shu-Feng Zhou, Manju Rawat Singh, Deependra Singh, Muhammad Nasir, Rakesh Sehgal, Alka Sehgal, Ram Sarup Singh and 2 more

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Lactoferrin: Properties and Potential Uses in the Food Industry.International journal of molecular sciences · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Lactoferrin affects in vitro and in vivo fertilization and implantation in rats.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jagat R KanwarNanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine (SoM), Molecular and Medical Research (MMR) Strategic Research Centre, Faculty of Health, Deakin University, Waurn Ponds, Victoria 3217, Australia. jagat.kanwar@deakin.edu.au.
Kislay RoyNanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine (SoM), Molecular and Medical Research (MMR) Strategic Research Centre, Faculty of Health, Deakin University, Waurn Ponds, Victoria 3217, Australia. k.roy@deakin.edu.au.
Yogesh PatelNanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine (SoM), Molecular and Medical Research (MMR) Strategic Research Centre, Faculty of Health, Deakin University, Waurn Ponds, Victoria 3217, Australia. yogeshpatel3545@gmail.com.
Shu-Feng ZhouDepartment of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA. szhou@health.usf.edu.
Manju Rawat SinghUniversity Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur 492 010, India. manjursu@gmail.com.
Deependra SinghUniversity Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur 492 010, India. deependraiop@gmail.com.
Muhammad NasirDepartment of Food Science & Human Nutrition, Faculty of Bio-Sciences, University of Veterinary & Animal Sciences, Lahore, Punjab 54000, Pakistan. nasir@uvas.edu.pk.
Rakesh SehgalDepartment of Medical Parasitology, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India. sehgalpgi@gmail.com.
Alka SehgalDepartment of Obstetrics & Gynecology, Government Medical College & Hospital, Sector 32, Chandigarh 160031, India. alkasehgal@rediffmail.com.
Ram Sarup SinghCarbohydrate and Protein Biotechnology Laboratory, Department of Biotechnology, Punjabi University, Patiala 147002, India. rssingh11@lycos.com.
Sanjay GargCentre for Pharmaceutical Innovation and Development (CPID), School of Pharmacy and Medical Sciences, University of South Australia, Adelaide SA 5000, Australia. sanjay.garg@unisa.edu.au.
Rupinder K KanwarNanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine (SoM), Molecular and Medical Research (MMR) Strategic Research Centre, Faculty of Health, Deakin University, Waurn Ponds, Victoria 3217, Australia. rupinder.kanwar@deakin.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactoferrin (Lf), an iron-binding protein from the transferrin family has been reported to have numerous functions. Even though Lf was first isolated from milk, it is also found in most exocrine secretions and in the secondary granules of neutrophils. Antimicrobial and anti-inflammatory activity reports on lactoferrin identified its significance in host defense against infection and extreme inflammation. Anticarcinogenic reports on lactoferrin make this protein even more valuable. This review is focused on the structural configuration of iron-containing and iron-free forms of lactoferrin obtained from different sources such as goat, camel and bovine. Apart for emphasizing on the specific beneficial properties of lactoferrin from each of these sources, the general antimicrobial, immunomodulatory and anticancer activities of lactoferrin are discussed here. Implementation of nanomedicinial strategies that enhance the bioactive function of lactoferrin are also discussed, along with information on lactoferrin in clinical trials.

Indexed as

AnimalsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsCamelusCattleClinical Trials as TopicGoatsHumansImmunity, InnateInflammationIronIron Chelating AgentsLactoferrinNeoplasmsNeutrophilsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsIronIron Chelating AgentsLactoferrinbovinecamelcancerimmunitylactoferrinnanoparticles

Identifiers

PMID26016555
PMCPMC6272382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.